Classical Hodgkin lymphoma is associated with frequent gains of 17q

被引:36
作者
Chui, DTY
Hammond, D
Baird, M
Shield, L
Jackson, R
Jarrett, RF
机构
[1] Univ Glasgow, Fac Vet Med, Inst Comparat Med, Leukaemia Res Fund Virus Ctr, Glasgow G61 1QH, Lanark, Scotland
[2] Univ Sheffield, Sch Med, Inst Canc Studies, Div Genom Med, Sheffield, S Yorkshire, England
[3] Glasgow Royal Infirm, Dept Pathol, Glasgow G4 0SF, Lanark, Scotland
关键词
D O I
10.1002/gcc.10266
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The etiology of Hodgkin lymphoma (HL) is poorly understood, and studies of the genetics of this disease have been hampered by the scarcity of the Hodgkin and Reed-Sternberg (HRS) cells within tumors. To determine whether recurrent genomic imbalances are a feature of HL, CD30-positive HRS cells were laser-microdissected from 20 classical Hodgkin lymphomas (cHLs) and four HL-derived cells lines and subjected to analyses by comparative genomic hybridization. In primary tumors, the most frequently involved chromosomal gains were 17q (70%), 2p (40%), 12q (40%), 17p (40%), 22q (35%), 9p (30%), 14q (30%), and 16p (30%), with minimal overlapping regions at 17q21, 2p23-13, 12q24, 17p13, 22q 13, 9p24-23, 14q32, 16p 13.3, and 16p11.2. The most frequent losses involved 13q (35%), 6q (30%), 11q (25%), and 4q (25%), with corresponding minimal overlapping regions at 13q21, 6q22, 11q22, and 4q32. Statistical analysis revealed significantly more gains of 2p and 14q in the older adult cases; loss of 13q was associated with a poor outcome. The results suggest that there is a set of recurrent chromosomal abnormalities associated with cHL and provide further evidence that cHL is genetically distinct from nodular lymphocyte predominance Hodgkin lymphoma (NLPHL). Abnormalities of 17q are infrequent in other lymphomas or NLPHL; this finding, coupled with current knowledge of gene expression in cHL, suggests that genes present on 17q may play an important role in the pathogenesis of cHL. (C) 2003 Wiley-Liss, Inc.
引用
收藏
页码:126 / 136
页数:11
相关论文
共 69 条
[51]   Clonal selection and learning in the antibody system [J].
Rajewsky, K .
NATURE, 1996, 381 (6585) :751-758
[52]   Genetic instability in Hodgkin's lymphoma [J].
Re, D ;
Zander, T ;
Diehl, V ;
Wolf, J .
ANNALS OF ONCOLOGY, 2002, 13 :19-22
[53]  
ROSENBERG SA, 1991, BIOL THER CANCER UPD, V1, P1
[54]   NEW CONSISTENT CHROMOSOMAL ABNORMALITY IN CHRONIC MYELOGENOUS LEUKEMIA IDENTIFIED BY QUINACRINE FLUORESCENCE AND GIEMSA STAINING [J].
ROWLEY, JD .
NATURE, 1973, 243 (5405) :290-293
[55]  
SanchezBeato M, 1996, J PATHOL, V180, P58, DOI 10.1002/(SICI)1096-9896(199609)180:1<58::AID-PATH610>3.0.CO
[56]  
2-W
[57]  
Sarris AH, 1999, HODGKIN'S DISEASE, P195
[58]   Comparative genomic hybridization analysis of natural killer cell lymphoma/leukemia - Recognition of consistent patterns of generic alterations [J].
Siu, LLP ;
Wong, KF ;
Chan, JKC ;
Kwong, YL .
AMERICAN JOURNAL OF PATHOLOGY, 1999, 155 (05) :1419-1425
[59]  
STEIN H, 2001, PATHOLOGY GENETICS T, P238
[60]   Expressed sequences as candidates for a novel tumor suppressor gene at band 13q14 in B-cell chronic lymphocytic leukemia and mantle cell lymphoma [J].
Stilgenbauer, S ;
Nickolenko, J ;
Wilhelm, J ;
Wolf, S ;
Weitz, S ;
Döhner, K ;
Boehm, T ;
Döhner, H ;
Lichter, P .
ONCOGENE, 1998, 16 (14) :1891-1897